iTonic Holdings

ITOC · NASDAQ

$2.80−$0.43 (−13.31%)TodayMarket closed · Oct 23, 7:30 PM ET

Prev close $3.23

About ITOC

iTonic Holdings Ltd. operates as a holding company with interests in providing healthcare solutions. The company is headquartered in Beijing, Beijing and currently employs 7 full-time employees. The company went IPO on 2024-09-05. The Company’s main businesses include development and commercialization of brachytherapy treatment planning system (TPS) specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. TPS is generally a computer software used in different types of radiotherapy. The Company’s main product is FTTPS, a user-oriented TPS for treating a wide variety of malignant tumors. Beijing Feitian’s product portfolio also includes Medical Auxiliary Supplies such as seed implant needles, computer workstations, patient positioning device and others.

Employees: 7
Headquarters: Beijing, Beijing
Listed: Sep 5, 2024
Sector: Health Care
Industry: Health Care Technology
Website: ftzy.com.cn

Leadership

iTonic Holdings executives
Name	Title	Since	Age
Jianfei Zhang	—	2023	52
Zhixin Li	—	—	41
Pengfei Zhang	—	—	51
Swee Leng Seng	—	—	61
Yun Fai Wong	—	—	36
Edward Ye	—	—	43

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.